Manufacture of oils and fats
NORDIC PHARMA INC AS
Revenue 2024
NOK 288.8m
Operating profit
NOK 57.2m
Equity
NOK 330.2m
Incorporated
2005
Employees
52
Share capital
NOK 27.9m
Key figures · 2024
Current ratio
5.79
Equity ratio
65.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 19.8% | |
| Net margin (%%) | 14.4% | |
| Return on assets (%%) | 11.4% | |
| Likviditet | ||
| Current ratio | 5.79 | |
| Working capital | 182.8m | |
| Soliditet | ||
| Equity ratio (%%) | 65.6% | |
| Debt-to-equity ratio | 0.53 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.